Ascendis Pharma AS DRC (A1SN34)

Currency in BRL
85.00
0.00(0.00%)
Closed·
A1SN34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
85.0085.00
52 wk Range
69.3094.05
Key Statistics
Bid/Ask
26.43 / 85.41
Prev. Close
85
Open
85
Day's Range
85-85
52 wk Range
69.3-94.05
Volume
-
Average Volume (3m)
179
1-Year Change
19.4156%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
A1SN34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Ascendis Pharma AS DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
2.83 / --
Revenue / Forecast
339.29M / --
EPS Revisions
Last 90 days

A1SN34 Income Statement

Compare A1SN34 to Peers and Sector

Metrics to compare
A1SN34
Peers
Sector
Relationship
P/E Ratio
19.0x−5.3x−0.4x
PEG Ratio
0.050.030.00
Price/Book
9.8x1.9x2.6x
Price / LTM Sales
13.5x4.7x3.1x
Upside (Analyst Target)
-31.6%47.9%
Fair Value Upside
Unlock−2.7%6.3%Unlock

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Employees
1189
Market
Brazil

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
19.54M29.64%1.66B
Other Institutional Investors
13.34M20.24%1.13B
Public Companies & Retail Investors
33.04M50.12%2.81B
Total
65.92M100.00%5.6B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
T. Rowe Price Group, Inc.20.66%13,618,8291,157,600
T. Rowe Price Capital Appreciation Fund, Inc.5.10%3,364,767286,005

FAQ

What Is the Ascendis Pharma AS (A1SN34) Stock Price Today?

The Ascendis Pharma AS stock price today is 85.00 BRL.

What Stock Exchange Does Ascendis Pharma AS Trade On?

Ascendis Pharma AS is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for Ascendis Pharma AS?

The stock symbol for Ascendis Pharma AS is "A1SN34."

What Is the Ascendis Pharma AS Market Cap?

As of today, Ascendis Pharma AS market cap is 84.69B BRL.

What Is Ascendis Pharma AS's Earnings Per Share (TTM)?

The Ascendis Pharma AS EPS (TTM) is 11.72.

From a Technical Analysis Perspective, Is A1SN34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Ascendis Pharma AS Stock Split?

Ascendis Pharma AS has split 0 times.

How Many Employees Does Ascendis Pharma AS Have?

Ascendis Pharma AS has 1189 employees.

What is the current trading status of Ascendis Pharma AS (A1SN34)?

As of Aug 17, 2026, Ascendis Pharma AS (A1SN34) is trading at a price of 85.00 BRL, with a previous close of 85.00 BRL. The stock has fluctuated within a day range of 85.00 BRL to 85.00 BRL, while its 52-week range spans from 69.30 BRL to 94.05 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.